Antigen clearing from porcine heart valves with preservation of structural integrity

International Journal of Artificial Organs

Volumn 29, Issue 8, 2006, Pages 781-789

  Ueda, Y ^a   Torrianni, Mark W ^a   Coppin, C M ^a   Iwai, S ^b   Sawa, Y ^b   Matsuda, H ^b  

^a MEDTRONIC INC   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Decellularization; Extracellular matrix scaffold; Xenogeneic heart valve tissue

Indexed keywords

ANTIGENS; DURABILITY; HEART; SCAFFOLDS (BIOLOGY); SOAPS (DETERGENTS); TISSUE;

BIOPROSTHESES; CARDIOVASCULAR TISSUES; CELLULAR INGROWTH; CHEMICAL FIXATION; DECELLULARIZATION; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX SCAFFOLD; HEART VALVES; IMMUNE REJECTION; XENOGENIC HEART VALVE TISSUE;

MAMMALS;

DETERGENT; DODECYL SULFATE SODIUM; HEART ANTIGEN; TRITON X 100;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART PRESERVATION; HEART VALVE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMATE; PROTEIN DEPLETION; QUANTUM YIELD; RABBIT; SWINE; TISSUE REGENERATION; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 33749262782     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900808     Document Type: Article

References (27)

1. Kuusisto J, Rasanen K, Sarkioja T, Alarakkola E, Kosma VM. Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: A necropsy study. Heart Journal 2005; 91: 576-82.
2. Neuenschwander S, Hoerstrup S. Heart valve tissue engineering. Transpl Immunol 2004; 12: 359-65.
3. Schenke-Layland K, Riemann I, Optiz F, Koning K, Halbhunter KJ, Stock UA. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biol 2004; 23: 113-25.
4. Schoen FJ. Pathology of bioprostheses and other tissue heart valve replacements. In: Silver MD, ed. Cardiovascular pathology, 2nd ed. New York: Churchill Livingstone; 1991. p 1547-605.
5. Sachs MS, Schoen FJ. Collagen fiber disruption occurs independent of calcification in clinically expolanted bioprosthetic heart valves. J Biomed Mat Res 2002: 62; 359-71.
6. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, Daniel W, Achenbach S. Progression of aortic valve calcification: Association with coronary atherosclerosis and cardiovascular risk factors. Circulation 2001; 104: 1927-32.
7. Grunkemeier GL, Bodnar E. Comparative assessment of bioprosthesis durability in the aortic position. J Heart Valve Disease 1995; 4: 49-55.
8. Grunkemeier GI, Bodnar E. Comparison of structural valve failure amone different "models" of homograft valves. J Heart Valve Dis 1994; 3: 556-60.
9. Schoen FJ, Levy RJ. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI April 28 - May 2, 1999. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999; 47: 439-65.
10. Mayer JE Jr. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg 1995; 7: 130-2.
11. Vongpatanasin W, Hill LD, Lange, RA. Prosthetic heart valves. N Engl J Med 1996; 335: 407-16.
12. Bader A, Schilling T, Teebken OE, et al. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Vasc Endovasc Surg 1998; 14: 279-84.
13. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6.
14. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002; 106 (suppl 1): S143-50.
15. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, et al. Tissue engineering of cardiac valve prostheses I: Development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 2002; 11: 457-62.
16. Kim WG, Park JK, Lee WY. Tissue-engineered heart valve leaflets: An effective method of obtaining acellularized valve xenografts. Int J Artif Organs 2002; 25: 791-7.
17. Courtman DW, Pereira CA, Kashef V, et al. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994; 28: 655-66.
18. Spina M, Ortolani F, Messlemani AE, et al. Isolation of intact aortic valve scaffolds of intact aortic valve scaffolds for heart-valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features. J Biomed Mater Res 2003; 67: 1338-50.
19. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995; 60 (suppl 2): S353-8.
20. Conklin BS, Richter ER, Kreutziger KL, Zhong DS, Chen C. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002; 24: 173-83.
21. Curtil A, Pegg DE, Wilson A. Freeze drying of cardiac valves in preparation for cell repopulation. Cryobiology 1997; 34: 13-22.
22. Courtman DW, Pereira CA, Omar S, Langdon SE, Lee JM, Wilson GJ. Biomechanical and ultrastructural comparison of cryopreservation and a novel cellular extraction of porcine aortic valve leaflets. J Biomed Mater Res 1995; 29: 1507-16.
23. Wilcox HE, Korossis SA, Booth C, Watterson KG, Kearney JN, Fisher J, Ingham E. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. J Heart Valve Dis 2005; 14: 228-37.
24. Fujisato T, Minatoya K, Yin M, Yamazaki S, Niwaya K, Kishida A, Nakatani T, Kitamura S. Vascular tissue regeneration using acellular scaffold in porcine model. Society for Biomaterials 30th Annual Meeting Transactions, Memphis, TN, April 27-30, 2005; p. 376, transaction: 454.
25. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B, Boltz-Nitulescu G, Gorlitzer M, Klepetko W, Wolner E, Ankersmit HJ. Alpha-Gal on bioprostheses: Xenograft immune response in cardiac surgery. Eur J Clin Invest 2005; 35: 17-23.
26. Allaire E, Guettier C, Bruneval P, Plissonier D, Michel JB. Cell-free arterial grafts: Morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg 1994; 19: 446-56.
27. Allaire E, Bruneval P, Mandet C, Becquemin JP, Michel JB. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 1967; 122: 73-81.